Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 370.70
+0.40 (0.11%)
Oct 1, 2026, 3:15 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 603.61 billion as of October 2, 2026. Its market cap has increased by 32.65% in one year.
Market Cap
603.61B
Enterprise Value
745.02B
Revenue
173.21B
Ranking
n/a
PE Ratio
110.10
Stock Price
370.70
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 603.61B, an increase of 1,229.15%. That is a compound annual growth rate of 12.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 603.61B | 14.83% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 489.84B |
| OneSource Specialty Pharma | 179.51B |
| Concord Biotech | 147.58B |
| Blue Jet Healthcare | 104.03B |
| Supriya Lifescience | 79.26B |
| Zota Health Care | 45.79B |
| Dishman Carbogen Amcis | 25.30B |
| Panacea Biotec | 22.45B |